SIMABS

Yes, SIMABS is currently active.

SIMABS's registered main activities are Research and experimental development on biotechnology, Manufacture of medicaments, Manufacture of other pharmaceutical products, Other information service activities, Other business support service activities n.e.c., Rental and operating of own or leased residential real estate, except social housing, Business and other management consultancy activities, Rental and operating of land, Activities of holding companies, Public relations and communication activities, Rental and operating of own or leased non-residential real estate, except land, Buying and selling of own real estate, Wholesale of pharmaceutical and medical goods, Rental and operating of social housing, Other liberal professions and professional, scientific and technical activities n.e.c., Other forms of education, Study, development of the production of active ingredients for drug manufacturing, and Tests and analyses relating to composition, physical characteristics, performance, compliance with regulatory texts and standards or specifications of materials, products, installation, etc.. It is also registered for 1 additional activity.

SIMABS's registered address is Agoralaan Abis, 3590 Diepenbeek, Belgium.

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), SIMABS reported 11.4 full-time equivalent employees.

SIMABS's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €1,474,700.

SIMABS's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

We have no B Corp certification on file for SIMABS.

No, SIMABS does not currently hold Fairtrade certification.